Tumor-LN-oC publishes end-user survey
The Tumor-LN-oC Organ-on-Chip (OoC) platform to be developed is thus targeting the monitoring of complex processes such as tissue crosstalk and metastasis and will serve as a platform for parallel preclinical testing of drugs for individual patients aiming at Precision Medicine approaches.
In order to better understand the end-user requirements, the project team prepared a short questionnaire on end-users’ needs and requirements from an Organ-on-Chip (OoC) platform for metastasis diagnosis and drug testing. The survey includes questions related to the operation, the analysis time, the cost and other information that in the end will co-shape the platform that will be developed during the course of the project.
More information is available at https://tumor-ln-oc.eu/
If you or anyone you know would be interested in contributing, please fill out the questionnaire here and don’t hesitate to get in touch with the team. The Tumor-LN-oC consortium thanks you for your participation!